United Kingdom
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 13.42 B
|
Dec. 31, 2023 | USD 139.72 | 1.32% |
|
United Kingdom |
|
2 |
USD 11.63 B
|
Dec. 31, 2023 | USD 17.52 | 3.51% |
|
United Kingdom |
|
3 |
USD 3.01 B
|
Dec. 31, 2023 | USD 4.69 | 1.09% |
|
United Kingdom |
|
4 |
USD 956.00 M
|
Dec. 31, 2023 | USD 12.64 | 1.05% |
|
United Kingdom |
|
5 |
USD 791.00 M
|
Dec. 31, 2023 | USD 27.14 | 2.12% |
|
United Kingdom |
|
6 |
USD 601.48 M
|
March 31, 2024 | USD 35.48 | -2.36% |
|
United Kingdom |
|
7 |
USD 455.50 M
|
Dec. 31, 2023 | USD 3.10 | 3.91% |
|
United Kingdom |
|
8 |
USD 314.52 M
|
Dec. 31, 2023 | USD 36.44 | -1.01% |
|
United Kingdom |
|
9 |
USD 294.16 M
|
Dec. 31, 2023 | USD 2.87 | -0.29% |
|
United Kingdom |
|
10 |
USD 242.25 M
|
Dec. 31, 2023 | USD 3.61 | -0.13% |
|
United Kingdom |
|
11 |
USD 197.53 M
|
June 30, 2024 | USD 42.30 | -1.02% |
|
United Kingdom |
|
12 |
USD 137.20 M
|
June 30, 2024 | USD 11.89 | 0.78% |
|
United Kingdom |
|
13 |
USD 117.47 M
|
March 31, 2024 | USD 25.74 | -4.49% |
|
United Kingdom |
|
14 |
USD 93.28 M
|
June 30, 2024 | USD 21.95 | 0.95% |
|
United Kingdom |
|
15 |
USD 90.08 M
|
Dec. 31, 2023 | USD 1.75 | -1.95% |
|
United Kingdom |
|
16 |
USD 45.29 M
|
Dec. 31, 2023 | USD 88.23 | -0.42% |
|
United Kingdom |
|
17 |
USD 39.95 M
|
Dec. 31, 2023 | USD 2.60 | -0.33% |
|
United Kingdom |
|
18 |
USD 39.02 M
|
Dec. 31, 2023 | USD 49.53 | 2.87% |
|
United Kingdom |
|
19 |
USD 19.27 M
|
Dec. 31, 2023 | USD 5.81 | 0.15% |
|
United Kingdom |
|
20 |
USD 17.84 M
|
Dec. 31, 2023 | USD 0.26 | 7.81% |
|
United Kingdom |
|
21 |
USD 15.56 M
|
Dec. 31, 2023 | USD 3.12 | -1.43% |
|
United Kingdom |
|
22 |
USD 14.08 M
|
April 30, 2024 | USD 0.66 | 4.07% |
|
United Kingdom |
|
23 |
USD 13.59 M
|
June 30, 2024 | USD 39.99 | 0.15% |
|
United Kingdom |
|
24 |
USD 12.66 M
|
June 30, 2024 | USD 4.69 | -1.82% |
|
United Kingdom |
|
25 |
USD 12.66 M
|
Dec. 31, 2023 | USD 0.46 | 1.73% |
|
United Kingdom |
|
26 |
USD 11.07 M
|
Dec. 30, 2023 | USD 76.23 | -0.83% |
|
United Kingdom |
|
27 |
USD 9.77 M
|
Dec. 31, 2023 | USD 0.33 | -0.23% |
|
United Kingdom |
|
28 |
USD 8.18 M
|
March 31, 2024 | USD 0.82 | 1.54% |
|
United Kingdom |
|
29 |
USD 7.64 M
|
March 31, 2024 | USD 2.87 | -5.99% |
|
United Kingdom |
|
30 |
USD 1.93 M
|
Dec. 31, 2023 | USD 2.01 | -1.09% |
|
United Kingdom |
|
31 |
USD 1.69 M
|
March 31, 2024 | USD 0.10 | 0.15% |
|
United Kingdom |
|
32 |
USD 446.00 K
|
Dec. 31, 2023 | USD 0.72 | -1.55% |
|
United Kingdom |
|
33 |
USD 431.11 K
|
Sept. 30, 2024 | USD 0.04 | 0.15% |
|
United Kingdom |
|
34 |
USD 0.00
|
Dec. 31, 2023 | USD 1.13 | 1.79% |
|
United Kingdom |
|
35 |
USD -15.75 K
|
March 31, 2024 | USD 1.03 | -1.91% |
|
United Kingdom |
|
36 |
USD -208.19 K
|
March 31, 2024 | USD 0.11 | 0.15% |
|
United Kingdom |
|
37 |
USD -835.12 K
|
June 30, 2024 | USD 0.01 | -11.38% |
|
United Kingdom |
|
38 |
USD -1.16 M
|
June 30, 2024 | USD 0.10 | 6.61% |
|
United Kingdom |
|
39 |
USD -1.20 M
|
Dec. 31, 2023 | USD 0.05 | 13.02% |
|
United Kingdom |
|
40 |
USD -1.31 M
|
Dec. 31, 2023 | USD 0.12 | 0.15% |
|
United Kingdom |
|
41 |
USD -1.45 M
|
Dec. 31, 2023 | USD 0.05 | 1.56% |
|
United Kingdom |
|
42 |
USD -1.75 M
|
Dec. 31, 2023 | USD 0.16 | -0.63% |
|
United Kingdom |
|
43 |
USD -1.98 M
|
March 31, 2024 | USD 0.15 | 2.28% |
|
United Kingdom |
|
44 |
USD -2.13 M
|
Sept. 30, 2024 | USD 0.15 | 0.15% |
|
United Kingdom |
|
45 |
USD -2.29 M
|
Dec. 31, 2023 | USD 0.02 | 0.15% |
|
United Kingdom |
|
46 |
USD -2.34 M
|
Dec. 31, 2023 | USD 0.20 | -7.11% |
|
United Kingdom |
|
47 |
USD -2.45 M
|
Dec. 31, 2023 | USD 0.05 | 4.32% |
|
United Kingdom |
|
48 |
USD -2.60 M
|
March 31, 2024 | USD 0.10 | -8.71% |
|
United Kingdom |
|
49 |
USD -3.08 M
|
Jan. 31, 2024 | USD 0.16 | 1.31% |
|
United Kingdom |
|
50 |
USD -3.34 M
|
Dec. 31, 2023 | USD 0.57 | 5.97% |
|
United Kingdom |
The Health Care company in United Kingdom with the highest EBITDA is AstraZeneca PLC (LSE: AZN.L) at USD 13.42 B.
The Health Care company in United Kingdom with the lowest EBITDA is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD -996.51 M.
The top 10 Health Care companies in United Kingdom by EBITDA are AstraZeneca PLC, GSK plc, Haleon plc, Smith & Nephew plc, Hikma Pharmaceuticals PLC, Halma plc, ConvaTec Group Plc, Spectris plc, Spire Healthcare Group plc and Domino's Pizza Group plc.
The bottom 10 Health Care companies in United Kingdom by EBITDA are Roivant Sciences Ltd., Oxford Biomedica plc, Bicycle Therapeutics plc, Centessa Pharmaceuticals plc, Autolus Therapeutics plc, Oxford Nanopore Technologies plc, COMPASS Pathways plc, Barinthus Biotherapeutics plc, Achilles Therapeutics plc and Silence Therapeutics plc.